公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | In response | Lai C.-C.; Tan C.-K.; Chou C.-H.; Hsu H.-L.; Liao C.-H.; YU-TSUNG HUANG ; PAN-CHYR YANG ; KWEN-TAY LUH ; PO-REN HSUEH | Emerging Infectious Diseases | 1 | 0 | |
2006 | In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan | Liao C.-H.; WANG-HUEI SHENG ; JANN-TAY WANG ; HSIN-YUN SUN ; Wang H.-K.; PO-REN HSUEH ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 26 | 0 | |
2002 | In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia | SHWU-JEN LIAW ; LEE-JENE TENG ; PO-REN HSUEH ; Ho S.-W.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 27 | 19 | |
2019 | In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan | Hsueh S.-C.; Lee Y.-J.; YU-TSUNG HUANG ; Liao C.-H.; Tsuji M.; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 82 | 73 | |
2023 | In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021 | Lee, Yu-Lin; Ko, Wen-Chien; PO-REN HSUEH | International journal of antimicrobial agents | 2 | 0 | |
2010 | In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | European Journal of Clinical Microbiology and Infectious Diseases | 21 | 16 | |
2009 | In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006 | Liu C.-Y.; Lu C.-L.; YU-TSUNG HUANG ; Liao C.-H.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 4 | 5 | |
2008 | In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan | Liu, Chia-Ying; YU-TSUNG HUANG ; Liao, Chun-Hsing; PO-REN HSUEH | Antimicrobial agents and chemotherapy | 20 | 17 | |
2005 | In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan | Cheng N.-C.; PO-REN HSUEH ; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | Microbial Drug Resistance | 28 | 26 | |
2007 | In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data | Hung M.-N.; PO-REN HSUEH ; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y.; KWEN-TAY LUH | International Journal of Antimicrobial Agents | 13 | 8 | |
2021 | In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020 | Liu, Po-Yu; Ko, Wen-Chien; Lee, Wen-Sen; Lu, Po-Liang; Chen, Yen-Hsu; Cheng, Shu-Hsing; Lu, Min-Chi; Lin, Chi-Ying; Wu, Ting-Shu; Yen, Muh-Yong; Wang, Lih-Shinn; Liu, Chang-Pan; PEI-LAN SHAO ; Lee, Yu-Lin; Shi, Zhi-Yuan; Chen, Yao-Shen; Wang, Fu-Der; Tseng, Shu-Hui; Lin, Chao-Nan; Chen, Yu-Hui; WANG-HUEI SHENG ; Lee, Chun-Ming; Tang, Hung-Jen; PO-REN HSUEH | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 17 | 10 | |
2018 | In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO ; Ko W.-C.; Wang F.-D.; PO-REN HSUEH | Infection and Drug Resistance | 34 | 34 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020 | Chang, Chih-Yen; Lee, Yu-Lin; YU-TSUNG HUANG ; Ko, Wen-Chien; Ho, Mao-Wang; PO-REN HSUEH | International journal of antimicrobial agents | 0 | 0 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020 | Lee, Yu Lin; Ko, Wen Chien; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 1 | 1 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020 | Liu, Yuag-Meng; Ko, Wen-Chien; Ho, Mao-Wang; Lee, Yu-Lin; PO-REN HSUEH | The Journal of infection | 2 | 2 | |
2007 | In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections | Tsai T.-Y.; SHAN-CHWEN CHANG ; PO-REN HSUEH ; Feng N.-H.; JANN-TAY WANG | Journal of Microbiology, Immunology and Infection | 19 | 0 | |
1998 | In vitro activity of meropenem against common pathogenic bacteria isolated in Taiwan | SHAN-CHWEN CHANG ; CHI-TAI FANG ; YEE-CHUN CHEN ; PO-REN HSUEH ; KWEN-TAY LUH ; Hsieh W.-C. | Diagnostic Microbiology and Infectious Disease | 8 | 6 | |
2009 | In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan | Chen Y.-H.; Liu C.-Y.; Lu J.-J.; King C.-H.R.; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 54 | 46 | |
2010 | In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007 | JYH-CHIN YANG ; PING-ING LEE ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 16 | 12 | |
1999 | In vitro activity of quinupristin/dalfopristin against clinical isolates of common gram-positive bacteria in Taiwan | SHAN-CHWEN CHANG ; CHI-TAI FANG ; PO-REN HSUEH ; KWEN-TAY LUH ; Hsieh W.-C. | Diagnostic Microbiology and Infectious Disease | 6 | 6 | |